Specific microbicides in the prevention of HIV infection
Authors:
- 27 October 2011
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 270 (6) , 509-519
Abstract
Kelly CG, Shattock RJ (Dental Institute, King's College London, London; and Imperial College, London; UK). Specific microbicides in the prevention of HIV infection (Symposium). J Intern Med 2011; 270: 509-519. Microbicides are products that are designed for application at vaginal or rectal mucosae to inhibit or block early events in HIV infection and thereby prevent transmission of HIV. Currently, the most advanced microbicides in the development pipeline are based on highly active anti-retroviral drugs (ARVs). Significant protection of women by vaginally applied tenofovir gel, demonstrated in the CAPRISA 004 trial, has provided proof-of-concept that microbicides can be effective. The rationale for investigating ARVs and other compounds as vaginal or rectal microbicides is discussed together with approaches to improve efficacy by the development of combination microbicides and by new formulations that may increase user acceptance.Keywords
This publication has 78 references indexed in Scilit:
- Early Events in Sexual Transmission of HIV and SIV and Opportunities for InterventionsAnnual Review of Medicine, 2011
- PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialThe Lancet, 2010
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trialThe Lancet, 2008
- Lack of Effectiveness of Cellulose Sulfate Gel for the Prevention of Vaginal HIV TransmissionNew England Journal of Medicine, 2008
- Human Immunodeficiency Virus Type 1 (HIV-1) Integration: a Potential Target for Microbicides To Prevent Cell-Free or Cell-Associated HIV-1 InfectionAntimicrobial Agents and Chemotherapy, 2008
- SAVVY® (C31G) Gel for Prevention of HIV infection in Women: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial in GhanaPLOS ONE, 2007
- Propagation and Dissemination of Infection after Vaginal Transmission of Simian Immunodeficiency VirusJournal of Virology, 2005
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmissionAIDS, 1999